The Department of Biomedicine

News archive for The Department of Biomedicine

UiB spin-off biotech company BergenBio announced that their drug bemcentinib is frast-tracked in a phase-II clinical trial as a potential treatment against COVID-19.
Have you ever considered doing a research stay abroad to broaden your scientific horizon? Postdoctor Sylvia Varland recently returned from a 2-year research stay at University of Toronto. Learn more about her scientific adventure and cultural experiences.